clarithromycin has been researched along with Bacterial Pneumonia in 95 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 20 (21.05) | 18.2507 |
2000's | 48 (50.53) | 29.6817 |
2010's | 21 (22.11) | 24.3611 |
2020's | 6 (6.32) | 2.80 |
Authors | Studies |
---|---|
Hammerschlag, MR; Kohlhoff, SA; Parker, C; Roblin, PM | 1 |
Al-Salloum, J; Gillani, SW; Gulam, SM; Mahmood, RK | 1 |
Aljabri, A; Almehmadi, M; Alqahtani, N; Alraddadi, B; Aseeri, MA; Assabban, Z; Bahobail, F; Botaish, A; Eljaaly, K; Hashim, A; Thabit, AK; Torres, A | 1 |
Adami, ME; Alexiou, N; Giamarellos-Bourboulis, EJ; Gogos, C; Halvatzis, S; Kosmas, V; Koutoukas, P; Kyprianou, A; Kyprianou, M; Kyriakoudi, A; Kyriazopoulou, E; Lada, M; Makina, A; Niederman, MS; Pavlaki, M; Sinapidis, D; Stefos, A; Velissaris, D | 1 |
Akyüz, S; Aşker, S; Baran, Aİ; Ekin, S; Özgökçe, M; Sünnetçioğlu, A; Turgut, E; Üney, İ; Yildiz, H | 1 |
Fujita, K; Hayakawa, H; Ito, Y; Iwaizumi, E; Kanai, M; Kojima, S; Miwa, S; Ohba, H; Oshima, T; Shirai, M; Suda, T | 1 |
Begbey, A; Guppy, JH; Mohan, C; Webster, S | 1 |
Inoue, Y; Kimura, Y; Kobayashi, T; Kurahara, Y; Minomo, S; Suzuki, K; Tsuji, T; Tsuyuguchi, K; Yoshida, S | 1 |
Adamopoulou, M; Giamarellos-Bourboulis, EJ; Kotanidou, A; Orfanos, SE; Raftogiannis, M; Renieris, G; Routsi, C; Sabracos, L; Strouvalis, I | 1 |
Harvey, E; Varatharaj, A | 1 |
Asteriades, S; Georgalas, I; Nasr, MB; Tranos, P; Vakalis, A | 1 |
Jeong, BH; Jeong, YJ; Kim, HJ; Koh, WJ; Lee, G; Lee, KS; Moon, JW; Woo, S | 1 |
Arnold, C; Bassetti, S; Piso, RJ | 1 |
Caumes, E; de Masson, A; Maillart, E; Meyssonnier, V; Papeix, C; Veziris, N | 1 |
Baraldo, M; Cojutti, P; Livi, U; Pea, F; Tursi, V | 1 |
Hara, A; Harada, T; Ishimatsu, Y; Izumikawa, K; Kakugawa, T; Kohno, S; Kosai, K; Morita, T; Mukae, H; Nakashima, S; Sakamoto, N; Yanagihara, K | 1 |
Astudillo, L; Couture, G; Geniez, C; Pugnet, G; Sailler, L | 1 |
Iida, K; Sasaoka, Y; Tatsumi, M; Tsutsumi, H; Yoto, Y | 1 |
Giguère, S | 1 |
McKinnell, J; Tayek, JA | 1 |
Hashino, S; Ohe, M | 1 |
Baranowski, WJ | 1 |
Barman, TK; Bhadauria, T; Bhateja, P; Bhatnagar, PK; Chakrabarti, A; Das, B; Katoch, R; Kumar, GR; Malhotra, S; Mathur, T; Pandya, M; Rao, M; Rathy, S; Upadhyay, D; Venkataraman, R | 1 |
Bai, N; Cai, Y; Chai, D; Liang, BB; Liu, Y; Wang, R | 1 |
Mikamo, H; Yamagishi, Y | 1 |
Fitting, JW; Greub, G; Jaton, K; Senn, L | 1 |
Cei, M; Mumoli, N | 1 |
Aarnoutse, RE; Boeree, MJ; Daley, CL; Egelund, EF; Heifets, LB; Levin, A; Mouton, JW; Peloquin, CA; Totten, SE; van Ingen, J | 1 |
Baglioni, S; Eslami, A; Todisco, C; Todisco, T | 1 |
Arita, M; Hashimoto, T; Ishida, T; Ito, I; Kishimoto, T; Mishima, M; Osawa, M | 1 |
Duprat-Lomon, I; Lamping, DL; Marquis, P; Marrel, A; Sagnier, PP; Schroter, S | 1 |
Chuah, SK; Gollapudi, S; Iskandar, L; Thadepalli, H | 1 |
Cabré, X; Falguera, M; Ferrer, G; Pérez, J; Ruiz, A; Sacristán, O; Vallverdú, M | 1 |
Cravarezza, P; Donati, P; Franchino, L; Grassi, V; Pozzi, A; Prometti, P; Ravizzola, G; Romanelli, G; Zulli, R | 1 |
Malcolm, C; Marrie, TJ | 1 |
Nagai, H | 1 |
García, E; González, J; Marco, F; Marcos, MA; Martínez, JA; Mensa, J; Sánchez, F; Soriano, A; Torres, A | 1 |
Carbon, C; Dunbar, L; Fogarty, C; Hagberg, L; Pullman, J; van Rensburg, DJ | 1 |
Becker, DL; Chancellor, JV; Drummond, MF; Duprat-Lomon, I; Hux, M; Kubin, R; Sagnier, PP | 1 |
Choudhri, S; Church, D; Grossman, C; Haverstock, D; Herman-Gnjidic, Z; Lode, H; McGivern, J | 1 |
Ninomiya, K | 1 |
Aizawa, H; Fujiki, R; Kawayama, T; Rikimaru, T | 1 |
Aronkyto, T; Chuchalin, AG; Jaaskevi, M; Kahnovskii, I; Kleutgens, K; Lode, H | 1 |
Banevicius, MA; Capitano, B; Geng, Q; Maglio, D; Nicolau, DP; Nightingale, CH | 1 |
Asche, CV; Chang, JR; Lavin, B; Niederman, MS; Nusrat, R; Stewart, J; Sullivan, SD | 1 |
Iutanova, NS | 1 |
Azam, S; Dhakam, S; Kiran, N | 1 |
Beecroft, MD; Herman-Gnjidic, Z; Marrie, TJ | 1 |
González-Granda, D; Labrador, T; Martínez, I; Nieto, A; Querol-Borrás, JM; Querol-Ribelles, JM; Tenías, JM | 1 |
García Vázquez, E; Marcos, MA; Martínez, JA; Mensa, J; Ortega, M; Puig, J; Torres, A | 1 |
Armstrong, EP; Malone, DC; Ramachandran, S; Skrepnek, GH | 1 |
Zar, HJ | 1 |
Bando, M; Ishii, Y; Ohno, S; Sugiyama, Y | 1 |
Lunn, JA; Malik, R; Martin, P; Zaki, S | 1 |
Morovic, M | 1 |
Dean, NC; Hadlock, C; Sperry, P; Suchyta, MS; Wikler, M | 1 |
Alvarez, J; Brown-Elliott, BA; Caccitolo, J; Girard, W; Graviss, EA; Griffith, DE; Langsjoen, B; Nelson, K; Pan, X; Shepherd, S; Wallace, RJ; Wilson, R; Zhang, Y | 1 |
Block, SL | 1 |
Barbe, F; García, M; Pifarre Teixido, R; Vicente de Vera, C | 1 |
Boswinkel, M; Sloet van Oldruitenborgh-Oosterbaan, MM | 1 |
Brumble, L; Garland, JL; Johnson, MM; Khoor, A; Roy, A; Waller, EA | 1 |
Ichihara, E; Kanehiro, A; Kiura, K; Kubo, T; Miyahara, N; Tabata, M; Takigawa, N; Tanimoto, M; Tanimoto, Y | 1 |
Decramer, M; Martin, M; Moore, L; Quilici, S; Simoens, S | 1 |
Delia, S; Iona, E; Mascellino, MT; Mastroianni, CM; Ponzo, R | 1 |
Fanti, D; Fraioli, P; Magliano, E; Montanari, G; Montemurro, L; Pozzoli, R; Rizzato, G | 1 |
Fung, CP; Jang, TN; Liu, CY; Wang, FD; Yang, SP | 1 |
Casas, JM; Gómez-Cadiñanos, RA; Oteo, JA; Rosel, L | 1 |
Dalhoff, K; Maass, M | 1 |
Hammerschlag, MR; Montalban, G; Roblin, PM | 1 |
Asnis, DS; Bresciani, AR; Cohn, M | 1 |
Borderas, F; Delgado, J; Gallardo, JA; Leal, M; Lissen, E; Macías, J; Pineda, JA; Sánchez-Quijano, A | 1 |
Block, SL; Harris, J; Kolokathis, A; Tarlow, MJ | 1 |
Huyghens, L; Lauwers, S; Meysman, M; Monsieur, I; Vincken, W | 1 |
Baraia-Etxaburu, J; Cisterna, R; Malero, P; Muñoz, J; Santamaría, JM; Teira, R; Unzaga, MJ | 1 |
de Torrenté, A; Genné, D; Humair, L; Janin-Jaquat, B; Siegrist, HH | 1 |
Klein, JO | 1 |
Burman, WJ; Dunne, EF; Wilson, ML | 1 |
Cadwgan, AM; Laing, RB; MacKenzie, AR | 1 |
Muller, O; O'Doherty, B | 1 |
Ramirez, J; Talbot, GH; Townsend, L; Unowsky, J; Zhang, H | 1 |
Higashiyama, Y; Kohno, S; Maesaki, S; Miyazaki, Y; Tashiro, T; Tomiyama, Y; Tomono, K; Yong, B | 1 |
Belda, A; Gonzalvo, F; Martínez-Moragón, E; Pascual, JM; Ripollés, F; Rovira, E | 1 |
Churchyard, GA; Dylewski, JS; Hagberg, L; Moola, S; Sedani, S; Staley, H | 1 |
Banevicius, MA; Bui, KQ; Nicolau, DP; Nightingale, CH; Quintiliani, R | 1 |
Bayliff, CD; Bombassaro, AM; McCormack, DG; Nolan, T; Offman, E; Varin, F | 1 |
Hammerschlag, MR; Roblin, PM | 1 |
Hammerschlag, MR | 1 |
Hamada, H; Hiwada, K; Kohno, N; Kondo, K; Yokoyama, A | 1 |
Koizumi, T; Kubo, K; Yaguchi, Y; Yamauchi, K; Yamazaki, Y; Yanagisawa, H | 1 |
Kroegel, C; Mock, B; Rödel, J | 1 |
Horikawa, S; Ikeue, T; Maekawa, N; Nishiyama, H; Sugita, T; Suzuki, Y; Ueshima, K; Watanabe, S | 1 |
Hanaoka, T; Katsuragi, N; Konno, H; Nakajima, Y; Shiraishi, Y; Takasuna, K | 1 |
Báñez, F; Biechy, M; Gálvez, E; Salgueró, E | 1 |
Bobbaers, H; Collins, O; Finch, R; Hoeffken, G; Izquierdo, JL; Kubin, R; McGivern, J; Nikolaides, P; Ogundare, F; Raz, R; Schürmann, D; Zuck, P | 1 |
Huth, RG; Jahn, B; Kamin, W; Knuf, M; Meyer, HG; Trübel, HK | 1 |
11 review(s) available for clarithromycin and Bacterial Pneumonia
Article | Year |
---|---|
Comparative efficacy of azithromycin versus clarithromycin in combination with beta-lactams to treat community-acquired pneumonia in hospitalized patients: a systematic review.
Topics: Adult; Anti-Bacterial Agents; Azithromycin; beta-Lactams; Clarithromycin; Community-Acquired Infections; Humans; Pneumonia, Bacterial | 2021 |
Systematic review and meta-analysis of the safety of erythromycin compared to clarithromycin in adults and adolescents with pneumonia.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Clarithromycin; Community-Acquired Infections; Erythromycin; Female; Humans; Male; Pneumonia, Bacterial | 2020 |
Treatment of Infections Caused by Rhodococcus equi.
Topics: Actinomycetales Infections; Animals; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Drug Resistance, Multiple, Bacterial; Erythromycin; Horse Diseases; Horses; Pneumonia, Bacterial; Rhodococcus equi; Rifampin | 2017 |
Effectiveness and safety of macrolides in cystic fibrosis patients: a meta-analysis and systematic review.
Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Cystic Fibrosis; Humans; Lung; Macrolides; Pneumonia, Bacterial; Randomized Controlled Trials as Topic; Respiratory Function Tests; Treatment Outcome | 2011 |
[Combination therapy with macrolides for pneumonia].
Topics: Aged; Anti-Bacterial Agents; Bacteria; Clarithromycin; Community-Acquired Infections; Drug Therapy, Combination; Humans; Macrolides; Male; Pneumonia, Bacterial; Practice Guidelines as Topic | 2011 |
[Nontuberculous mycobacteriosis].
Topics: Clarithromycin; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Pneumonia, Bacterial; Prognosis; Rifampin; Streptomycin | 2003 |
Telithromycin in the treatment of community-acquired pneumonia: a pooled analysis.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Clinical Trials, Phase III as Topic; Community-Acquired Infections; Double-Blind Method; Fluoroquinolones; Humans; Ketolides; Macrolides; Naphthyridines; Penicillins; Pneumonia, Bacterial; Randomized Controlled Trials as Topic; Treatment Outcome | 2003 |
Neonatal chlamydial infections: prevention and treatment.
Topics: Anti-Bacterial Agents; Azithromycin; Chlamydia Infections; Clarithromycin; Humans; Infant, Newborn; Ophthalmia Neonatorum; Pneumonia, Bacterial; Roxithromycin | 2005 |
[Diagnosis and therapy of Rhodococcus equi infection in the horse].
Topics: Actinomycetales Infections; Animals; Animals, Newborn; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Drug Therapy, Combination; Erythromycin; Horse Diseases; Horses; Pneumonia, Bacterial; Rhodococcus equi; Rifampin; Treatment Outcome | 2006 |
Future indications for macrolides.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-Bacterial Agents; Azithromycin; Bacterial Infections; Child; Child, Preschool; Clarithromycin; Community-Acquired Infections; Helicobacter Infections; Humans; Malaria; Mycobacterium avium-intracellulare Infection; Pneumonia, Bacterial | 1997 |
Streptomyces pneumonia in a patient with human immunodeficiency virus infection: case report and review of the literature on invasive streptomyces infections.
Topics: Actinomycetales Infections; Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Clarithromycin; Humans; Male; Pneumonia, Bacterial; Streptomyces | 1998 |
27 trial(s) available for clarithromycin and Bacterial Pneumonia
Article | Year |
---|---|
Early increase of VEGF-A is associated with resolution of ventilator-associated pneumonia: Clinical and experimental evidence.
Topics: Animals; Anti-Bacterial Agents; APACHE; Biomarkers; Bronchoalveolar Lavage Fluid; Clarithromycin; Double-Blind Method; Humans; Interferon-gamma; Interleukin-1beta; Mice; Peroxidase; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Time Factors; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A | 2018 |
An open, comparative pilot study of thiamphenicol glycinate hydrochloride vs clarithromycin in the treatment of acute lower respiratory tract infections due to Chlamydia pneumoniae.
Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Chlamydophila Infections; Chlamydophila pneumoniae; Clarithromycin; Drug Administration Schedule; Female; Humans; Immunoglobulins; Male; Middle Aged; Pilot Projects; Pneumonia, Bacterial; Radiography; Thiamphenicol; Treatment Outcome | 2002 |
The community-acquired pneumonia symptom questionnaire: a new, patient-based outcome measure to evaluate symptoms in patients with community-acquired pneumonia.
Topics: Adult; Aged; Amoxicillin; Anti-Infective Agents; Aza Compounds; Clarithromycin; Community-Acquired Infections; Double-Blind Method; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Outcome Assessment, Health Care; Pneumonia, Bacterial; Psychometrics; Quality Assurance, Health Care; Quinolines; Surveys and Questionnaires | 2002 |
[Community-acquired pneumonia: usefulness of clinical presentation in the selection of antibiotic treatment].
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Community-Acquired Infections; Female; Hospitalization; Humans; Length of Stay; Levofloxacin; Male; Middle Aged; Ofloxacin; Penicillins; Pneumonia, Bacterial; Treatment Outcome | 2002 |
Carbapenems in the treatment of severe community-acquired pneumonia in hospitalized elderly patients: a comparative study against standard therapy.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Ceftriaxone; Cilastatin; Cilastatin, Imipenem Drug Combination; Clarithromycin; Community-Acquired Infections; Costs and Cost Analysis; Drug Combinations; Drug Costs; Drug Therapy, Combination; Female; Hospitalization; Humans; Imipenem; Male; Meropenem; Pneumonia, Bacterial; Prospective Studies; Thienamycins; Treatment Outcome | 2002 |
Is azithromycin the first-choice macrolide for treatment of community-acquired pneumonia?
Topics: Adult; Aged; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Community-Acquired Infections; Follow-Up Studies; Humans; Length of Stay; Middle Aged; Pneumonia, Bacterial; Prospective Studies; Treatment Outcome | 2003 |
Sequential IV/PO moxifloxacin treatment of patients with severe community-acquired pneumonia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aza Compounds; Clarithromycin; Community-Acquired Infections; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Naphthyridines; Pneumonia, Bacterial; Quinolines; Retrospective Studies; Treatment Outcome | 2003 |
[Beneficial effects of macrolide antibiotics on children with influenza].
Topics: Adolescent; Bacteria; Child; Child, Preschool; Clarithromycin; Drug Resistance, Bacterial; Erythromycin; Female; Humans; Infant; Influenza, Human; Male; Pharynx; Pneumonia, Bacterial; Treatment Outcome | 2003 |
[Clinical efficacy of oral clarithromycin monotherapy in patients with mild or moderate community-acquired pneumonia].
Topics: Administration, Oral; Adolescent; Adult; Aged; Anti-Bacterial Agents; Clarithromycin; Community-Acquired Infections; Female; Haemophilus influenzae; Humans; Male; Middle Aged; Mycoplasma pneumoniae; Pneumonia, Bacterial; Severity of Illness Index; Streptococcus pneumoniae; Treatment Outcome | 2003 |
A randomised, double-blind, double-dummy comparative study of gatifloxacin with clarithromycin in the treatment of community-acquired pneumonia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; Community-Acquired Infections; Double-Blind Method; Drug Resistance, Bacterial; Female; Fluoroquinolones; Gatifloxacin; Humans; Male; Middle Aged; Pneumonia, Bacterial; Treatment Outcome | 2004 |
Hospitalization rates among patients with community-acquired pneumonia treated with telithromycin vs clarithromycin: results from two randomized, double-blind, clinical trials.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; Community-Acquired Infections; Double-Blind Method; Female; Hospitalization; Humans; Ketolides; Macrolides; Male; Middle Aged; Pneumonia, Bacterial | 2004 |
[Clinical efficacy of clarithromycin delayed release dosage form in the treatment of community-acquired pneumonia].
Topics: Adolescent; Adult; Anti-Bacterial Agents; Clarithromycin; Community-Acquired Infections; Delayed-Action Preparations; Female; Haemophilus influenzae; Humans; Male; Middle Aged; Pneumonia, Bacterial; Staphylococcus aureus; Streptococcus pneumoniae | 2004 |
Resolution of symptoms in patients with community-acquired pneumonia treated on an ambulatory basis.
Topics: Adult; Ambulatory Care; Anti-Bacterial Agents; Aza Compounds; Clarithromycin; Community-Acquired Infections; Double-Blind Method; Female; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Pneumonia, Bacterial; Prospective Studies; Quinolines; Severity of Illness Index; Treatment Outcome | 2004 |
Levofloxacin versus ceftriaxone plus clarithromycin in the treatment of adults with community-acquired pneumonia requiring hospitalization.
Topics: Aged; Anti-Bacterial Agents; Ceftriaxone; Clarithromycin; Cohort Studies; Community-Acquired Infections; Drug Therapy, Combination; Female; Hospitalization; Humans; Levofloxacin; Male; Ofloxacin; Pneumonia, Bacterial; Prospective Studies; Treatment Outcome | 2005 |
Q Fever pneumonia: are clarithromycin and moxifloxacin alternative treatments only?
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Aza Compounds; Child; Clarithromycin; Coxiella burnetii; Doxycycline; Female; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Pneumonia, Bacterial; Q Fever; Quinolines; Treatment Outcome | 2005 |
Comparing gatifloxacin and clarithromycin in pneumonia symptom resolution and process of care.
Topics: Adult; Aged; Anti-Bacterial Agents; Ceftriaxone; Clarithromycin; Community-Acquired Infections; Drug Therapy, Combination; Fluoroquinolones; Gatifloxacin; Humans; Length of Stay; Middle Aged; Pneumonia, Bacterial; Prospective Studies | 2006 |
Comparative tolerability, safety and efficacy of tablet formulations of twice-daily clarithromycin 250 mg versus once-daily extended-release clarithromycin 500 mg in pediatric and adolescent patients.
Topics: Adolescent; Anti-Bacterial Agents; Chemistry, Pharmaceutical; Child; Clarithromycin; Drug Administration Schedule; Female; Humans; Male; Pharyngitis; Pneumonia, Bacterial; Sinusitis; Skin Diseases, Bacterial; Streptococcal Infections; Tablets; Treatment Outcome | 2006 |
Efficacy of a three day course of azithromycin in moderately severe community-acquired pneumonia.
Topics: Adult; Azithromycin; Clarithromycin; Community-Acquired Infections; Drug Administration Schedule; Female; Hospitalization; Humans; Male; Middle Aged; Pneumonia, Bacterial; Treatment Outcome | 1995 |
A randomized comparative study on the safety and efficacy of clarithromycin and erythromycin in treating community-acquired pneumonia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Clarithromycin; Erythromycin; Female; Humans; Male; Middle Aged; Pneumonia, Bacterial | 1995 |
Susceptibilities to clarithromycin and erythromycin of isolates of Chlamydia pneumoniae from children with pneumonia.
Topics: Child; Child, Preschool; Chlamydia Infections; Chlamydophila pneumoniae; Clarithromycin; Erythromycin; Humans; Microbial Sensitivity Tests; Pneumonia, Bacterial | 1994 |
Clarithromycin versus amoxicillin-clavulanic acid in the treatment of community-acquired pneumonia.
Topics: Adult; Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Clarithromycin; Community-Acquired Infections; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Pneumonia, Bacterial; Prospective Studies | 1997 |
Randomized, multicentre study of the efficacy and tolerance of azithromycin versus clarithromycin in the treatment of adults with mild to moderate community-acquired pneumonia. Azithromycin Study Group.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Community-Acquired Infections; Female; Humans; Male; Middle Aged; Pneumonia, Bacterial; Treatment Outcome | 1998 |
Sparfloxacin versus clarithromycin in the treatment of community-acquired pneumonia.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Community-Acquired Infections; Double-Blind Method; Female; Fluoroquinolones; Humans; Male; Middle Aged; Pneumonia, Bacterial; Quinolones | 1999 |
Treatment of community-acquired pneumonia in outpatients: randomized study of clarithromycin alone versus clarithromycin and cefuroxime.
Topics: Adult; Anti-Bacterial Agents; Cefuroxime; Cephalosporins; Clarithromycin; Community-Acquired Infections; Drug Therapy, Combination; Female; Humans; Male; Pneumonia, Bacterial | 1999 |
A multicenter study of grepafloxacin and clarithromycin in the treatment of patients with community-acquired pneumonia.
Topics: Adult; Aged; Anti-Infective Agents; Clarithromycin; Community-Acquired Infections; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Fluoroquinolones; Humans; Male; Middle Aged; Piperazines; Pneumonia, Bacterial; Prospective Studies; Treatment Outcome | 1999 |
Microbiologic efficacy of moxifloxacin for the treatment of community-acquired pneumonia due to Chlamydia pneumoniae.
Topics: Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Chlamydia Infections; Chlamydophila pneumoniae; Clarithromycin; Community-Acquired Infections; Fluoroquinolones; Humans; Inhibitory Concentration 50; Microbial Sensitivity Tests; Moxifloxacin; Nasopharynx; Pneumonia, Bacterial; Quinolines | 2000 |
Randomized controlled trial of sequential intravenous (i.v.) and oral moxifloxacin compared with sequential i.v. and oral co-amoxiclav with or without clarithromycin in patients with community-acquired pneumonia requiring initial parenteral treatment.
Topics: Administration, Oral; Adult; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Bacteria; Clarithromycin; Community-Acquired Infections; Double-Blind Method; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Pneumonia, Bacterial; Quinolines | 2002 |
57 other study(ies) available for clarithromycin and Bacterial Pneumonia
Article | Year |
---|---|
In vitro activity of CEM-101, a new fluoroketolide antibiotic, against Chlamydia trachomatis and Chlamydia (Chlamydophila) pneumoniae.
Topics: Adult; Anti-Bacterial Agents; Child; Child, Preschool; Chlamydia Infections; Chlamydia trachomatis; Chlamydophila Infections; Chlamydophila pneumoniae; Female; Humans; Infant; Macrolides; Microbial Sensitivity Tests; Pneumonia, Bacterial; Triazoles | 2010 |
Survival benefit associated with clarithromycin in severe community-acquired pneumonia: A matched comparator study.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Azithromycin; beta-Lactams; Clarithromycin; Cohort Studies; Community-Acquired Infections; Female; Fluoroquinolones; Humans; Macrolides; Male; Middle Aged; Pneumonia, Bacterial; Treatment Outcome | 2020 |
Delftia acidovorans pneumonia with lung cavities formation.
Topics: Anti-Bacterial Agents; Clarithromycin; Delftia acidovorans; Female; Gram-Negative Bacterial Infections; Humans; Immunocompromised Host; Lung; Middle Aged; Piperacillin, Tazobactam Drug Combination; Pneumonia, Bacterial; Tomography, X-Ray Computed | 2019 |
Macrolide resistant Mycobacterium avium complex pulmonary disease following clarithromycin and ethambutol combination therapy.
Topics: Aged; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Ethambutol; Female; Humans; Incidence; Japan; Macrolides; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Negative Results; Pneumonia, Bacterial; Rifampin | 2020 |
Topics: Adult; Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Comorbidity; Crohn Disease; Enterobacteriaceae Infections; Female; Hafnia alvei; Humans; Immunocompromised Host; Male; Pneumonia, Bacterial; Pulmonary Disease, Chronic Obstructive; Rare Diseases; Treatment Outcome; Young Adult | 2020 |
Resumption/efficacy and safety of an azithromycin-containing regimen against Mycobacterium avium complex lung disease in patients who experienced adverse effects with a clarithromycin-containing regimen.
Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Pneumonia, Bacterial; Retrospective Studies; Treatment Outcome | 2021 |
Round pneumonia.
Topics: Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Clarithromycin; Diagnosis, Differential; Female; Humans; Pneumonia, Bacterial; Tomography, X-Ray Computed | 2014 |
Bilateral diffuse iris atrophy after the use of oral clarithromycin.
Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Atrophy; Clarithromycin; Female; Humans; Iris; Iris Diseases; Pneumonia, Bacterial | 2014 |
Nodular bronchiectatic Mycobacterium avium complex pulmonary disease. Natural course on serial computed tomographic scans.
Topics: Aged; Anti-Bacterial Agents; Azithromycin; Bronchiectasis; Clarithromycin; Disease Progression; Drug Therapy, Combination; Ethambutol; Female; Humans; Lung; Male; Middle Aged; Multiple Pulmonary Nodules; Multivariate Analysis; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Pneumonia, Bacterial; Proportional Hazards Models; Retrospective Studies; Rifampin; Tomography, X-Ray Computed | 2013 |
Coverage of atypical pathogens for hospitalised patients with community-acquired pneumonia is not guided by clinical parameters.
Topics: Adult; Age Factors; Aged; Anti-Bacterial Agents; beta-Lactams; Chlamydial Pneumonia; Clarithromycin; Community-Acquired Infections; Drug Therapy, Combination; Guideline Adherence; Hospitalization; Humans; Immunocompromised Host; Legionnaires' Disease; Macrolides; Male; Middle Aged; Odds Ratio; Pneumonia, Bacterial; Pneumonia, Mycoplasma; Pneumonia, Pneumococcal; Practice Guidelines as Topic; Practice Patterns, Physicians'; Retrospective Studies; Severity of Illness Index | 2013 |
Cavitary pulmonary disease in a patient treated with natalizumab.
Topics: Adult; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Antitubercular Agents; Clarithromycin; Ethambutol; Female; Humans; Multiple Sclerosis, Relapsing-Remitting; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Natalizumab; Pneumonia, Bacterial | 2014 |
Everolimus overexposure in a heart transplant patient receiving clarithromycin for the treatment of pneumonia.
Topics: Aged; Anti-Bacterial Agents; Clarithromycin; Drug Interactions; Everolimus; Female; Heart Transplantation; Humans; Immunosuppressive Agents; Pneumonia, Bacterial | 2015 |
Premedication with Clarithromycin Is Effective against Secondary Bacterial Pneumonia during Influenza Virus Infection in a Pulmonary Emphysema Mouse Model.
Topics: Animals; Bacterial Load; Cell Count; Chemokines; Clarithromycin; Coinfection; Disease Models, Animal; Influenza A Virus, H1N1 Subtype; Lung; Mice; Neutrophils; Orthomyxoviridae Infections; Pneumonia, Bacterial; Pulmonary Emphysema; Streptococcus pneumoniae; Survival Analysis; Viral Load | 2016 |
[Second case of serum sickness-like reaction to claritrhomycin].
Topics: Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents, Non-Steroidal; Clarithromycin; Drug Therapy, Combination; Female; Humans; Pneumonia, Bacterial; Serum Sickness | 2016 |
Neonatal apnea with Chlamydia pneumoniae infection.
Topics: Anti-Bacterial Agents; Apnea; Chlamydophila pneumoniae; Clarithromycin; Gestational Age; Humans; Infant, Newborn; Infant, Newborn, Diseases; Male; Oxygen Consumption; Pneumonia, Bacterial; Polymerase Chain Reaction | 2017 |
Short term treatment with clarithromycin resulting in colchicine-induced rhabdomyolysis.
Topics: Anti-Bacterial Agents; Ceftriaxone; Clarithromycin; Colchicine; Community-Acquired Infections; Doxycycline; Drug Interactions; Gout; Gout Suppressants; Humans; Male; Middle Aged; Pneumonia, Bacterial; Rhabdomyolysis; Treatment Outcome | 2009 |
[Successful treatment with clarithromycin for Mixed phenotype acute leukemia, T/myeloid, NOS].
Topics: Acute Disease; Aged; Anti-Bacterial Agents; Clarithromycin; Drug Synergism; Drug Therapy, Combination; Female; Humans; Leukemia; Leukemia, Myeloid, Acute; Pneumonia, Bacterial; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone | 2010 |
Clarithromycin-induced hypomania in a child - a case report.
Topics: Administration, Oral; Anti-Bacterial Agents; Bipolar Disorder; Child, Preschool; Clarithromycin; Community-Acquired Infections; Humans; Male; Pneumonia, Bacterial | 2010 |
Activity of a novel series of acylides active against community-acquired respiratory pathogens.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Clarithromycin; Community-Acquired Infections; Drug Evaluation, Preclinical; Haemophilus influenzae; Humans; Mice; Microbial Sensitivity Tests; Moraxella catarrhalis; Pneumonia, Bacterial; Pneumonia, Pneumococcal; Streptococcus pneumoniae; Time Factors | 2010 |
Does respiratory infection due to Chlamydia pneumoniae still exist?
Topics: Adolescent; Bacterial Load; Chlamydophila Infections; Chlamydophila pneumoniae; Clarithromycin; Cough; Diagnosis, Differential; DNA, Bacterial; Female; Humans; Male; Middle Aged; Nasopharynx; Pneumonia, Bacterial; Polymerase Chain Reaction; Respiratory Tract Infections; Sputum | 2011 |
Clinical images: community-acquired pneumonia.
Topics: Adult; Anti-Bacterial Agents; Chest Pain; Clarithromycin; Community-Acquired Infections; Cough; Humans; Leukocyte Count; Lung; Male; Penicillins; Pneumonia, Bacterial; Radiography; Severity of Illness Index | 2012 |
The pharmacokinetics and pharmacodynamics of pulmonary Mycobacterium avium complex disease treatment.
Topics: Adult; Aged; Amikacin; Antibiotics, Antitubercular; Area Under Curve; Clarithromycin; Cohort Studies; Colorado; Drug Interactions; Drug Resistance, Bacterial; Drug Therapy, Combination; Ethambutol; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Pneumonia, Bacterial; Retrospective Studies; Rifabutin; Rifampin | 2012 |
Familial cases of psittacosis: possible person-to-person transmission.
Topics: Adult; Anti-Bacterial Agents; Clarithromycin; Disease Transmission, Infectious; Female; Fluorescent Antibody Technique; Humans; Immunocompromised Host; Pneumonia, Bacterial; Primary Myelofibrosis; Psittacosis; Treatment Outcome | 2002 |
Comparison of telithromycin, a new ketolide, with erythromycin and clarithromycin for the treatment of Haemophilus influenzae pneumonia in suckling, middle aged and senescent mice.
Topics: Aging; Animals; Animals, Suckling; Anti-Bacterial Agents; Area Under Curve; Clarithromycin; Drug Administration Schedule; Drug Evaluation, Preclinical; Erythromycin; Haemophilus influenzae; Ketolides; Lung; Macrolides; Mice; Pneumonia, Bacterial; Tissue Distribution | 2002 |
Antibiotic therapy for ambulatory patients with community-acquired pneumonia in an emergency department setting.
Topics: Adolescent; Adult; Aged; Alberta; Ambulatory Care; Analysis of Variance; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Community-Acquired Infections; Emergency Service, Hospital; Female; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Pneumonia, Bacterial; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Treatment Outcome | 2003 |
An economic evaluation of sequential i.v./po moxifloxacin therapy compared to i.v./po co-amoxiclav with or without clarithromycin in the treatment of community-acquired pneumonia.
Topics: Administration, Oral; Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents; Aza Compounds; Clarithromycin; Community-Acquired Infections; Cost-Benefit Analysis; Drug Therapy, Combination; Female; Fluoroquinolones; France; Germany; Hospitalization; Humans; Injections, Intravenous; Male; Middle Aged; Moxifloxacin; Pneumonia, Bacterial; Quinolines; Randomized Controlled Trials as Topic | 2003 |
Differential efficacy of clarithromycin in lung versus thigh infection models.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Clarithromycin; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Female; Lung; Mice; Microbial Sensitivity Tests; Pneumonia, Bacterial; Streptococcal Infections; Streptococcus pneumoniae; Thigh | 2004 |
Clarithromycin induced digoxin toxicity: case report and review.
Topics: Anti-Bacterial Agents; Anticoagulants; Atrial Fibrillation; Clarithromycin; Digoxin; Drug Interactions; Drug Therapy, Combination; Female; Humans; Middle Aged; Pneumonia, Bacterial; Warfarin | 2004 |
Lower mortality among patients with community-acquired pneumonia treated with a macrolide plus a beta-lactam agent versus a beta-lactam agent alone.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Azithromycin; Cefotaxime; Ceftriaxone; Clarithromycin; Community-Acquired Infections; Drug Therapy, Combination; Erythromycin; Humans; Pneumonia, Bacterial | 2005 |
An economic and outcomes assessment of first-line monotherapy in the treatment of community-acquired pneumonia within managed care.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Community-Acquired Infections; Databases as Topic; Erythromycin; Female; Health Care Costs; Humans; Levofloxacin; Male; Managed Care Programs; Middle Aged; Models, Econometric; Ofloxacin; Pneumonia, Bacterial; Retrospective Studies; Risk Assessment; Treatment Outcome | 2005 |
[A travel abroad-associated case of Legionella pneumonia diagnosed by urinary antigen detection test].
Topics: Aged; Anti-Bacterial Agents; Antigens, Bacterial; Clarithromycin; Drug Therapy, Combination; Fluoroquinolones; Humans; Immunologic Tests; Legionella pneumophila; Legionnaires' Disease; Male; Oxazines; Pneumonia, Bacterial; Travel; Turkey | 2005 |
Pneumonia due to Mycobacterium abscessus in two domestic ferrets (Mustelo putorius furo).
Topics: Animals; Anti-Bacterial Agents; Bronchoalveolar Lavage Fluid; Clarithromycin; Female; Ferrets; Mycobacterium; Mycobacterium Infections; Pneumonia, Bacterial; Treatment Outcome | 2005 |
Clinical and molecular analysis of macrolide resistance in Mycobacterium avium complex lung disease.
Topics: Aged; Anti-Infective Agents; Bacterial Proteins; Chaperonin 60; Chaperonins; Clarithromycin; Drug Resistance, Bacterial; Female; Humans; Macrolides; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Pneumonia, Bacterial; Polymerase Chain Reaction; Prognosis; Retrospective Studies; RNA, Bacterial | 2006 |
Delirium induced by clarithromycin in a patient with community-acquired pneumonia.
Topics: Anti-Bacterial Agents; Clarithromycin; Community-Acquired Infections; Delirium; Female; Humans; Middle Aged; Pneumonia, Bacterial | 2006 |
The expanding spectrum of Mycobacterium avium complex-associated pulmonary disease.
Topics: Adult; Amikacin; Biopsy; Clarithromycin; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Female; Granuloma; Humans; Lung; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Necrosis; Pneumonia, Bacterial; Prednisone; Rifampin; Sputum; Tomography, X-Ray Computed | 2006 |
[Coinfection with Mycoplasma pneumoniae and Chlamydophila pneumoniae in a middle-aged adult].
Topics: Anti-Bacterial Agents; Chlamydophila Infections; Chlamydophila pneumoniae; Clarithromycin; Humans; Male; Middle Aged; Mycoplasma pneumoniae; Pneumonia, Bacterial; Pneumonia, Mycoplasma; Treatment Outcome | 2007 |
A cost-effectiveness analysis of antimicrobial treatment of community-acquired pneumonia taking into account resistance in Belgium.
Topics: Amoxicillin; Anti-Bacterial Agents; Aza Compounds; Belgium; Cefuroxime; Clarithromycin; Community-Acquired Infections; Cost-Benefit Analysis; Decision Support Techniques; Drug Costs; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Fluoroquinolones; Humans; Moxifloxacin; Pneumonia, Bacterial; Quinolines | 2008 |
Infections due to Rhodococcus equi in three HIV-infected patients: microbiological findings and antibiotic susceptibility.
Topics: Actinomycetales Infections; Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Azithromycin; Bacteremia; Bronchoalveolar Lavage Fluid; Clarithromycin; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Erythromycin; Female; Gentamicins; HIV Infections; Humans; Imipenem; Male; Pleurisy; Pneumonia, Bacterial; Rhodococcus equi; Rifampin; Sputum; Teicoplanin; Vancomycin | 1994 |
Clarithromycin-induced thrombocytopenic purpura.
Topics: Aged; Clarithromycin; Community-Acquired Infections; Humans; Male; Pneumonia, Bacterial; Purpura, Thrombocytopenic | 1994 |
[Isolation of Chlamydia pneumoniae in atypical pneumonia].
Topics: Adult; Bronchoalveolar Lavage Fluid; Cefuroxime; Chlamydia Infections; Chlamydophila pneumoniae; Clarithromycin; DNA, Bacterial; Fluorescent Antibody Technique; Follow-Up Studies; Humans; Male; Pneumonia, Bacterial; Polymerase Chain Reaction; Recurrence | 1994 |
Mycobacterium avium-intracellulare complex pneumonia in a non-HIV-infected individual: an increasingly recognized disease.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Antitubercular Agents; Ciprofloxacin; Clarithromycin; Drug Therapy, Combination; Ethambutol; HIV Seronegativity; Humans; Male; Mycobacterium avium-intracellulare Infection; Necrosis; Pneumonia, Bacterial; Pulmonary Atelectasis; Rifampin | 1996 |
Rhodococcus or mycobacterium? An example of misdiagnosis in HIV infection.
Topics: Actinomycetales Infections; Adult; AIDS-Related Opportunistic Infections; Ciprofloxacin; Clarithromycin; Diagnostic Errors; Drug Therapy, Combination; Humans; Mycobacterium Infections; Pneumonia, Bacterial; Rhodococcus equi; Rifampin; Vancomycin | 1997 |
Severe community-acquired pneumonia caused by atypical organisms.
Topics: Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cefuroxime; Cephalosporins; Clarithromycin; Clavulanic Acids; Community-Acquired Infections; Critical Care; Diagnosis, Differential; Drug Therapy, Combination; Erythromycin; Female; Gentamicins; Humans; Male; Middle Aged; Netilmicin; Pneumonia, Bacterial; Pneumonia, Mycoplasma; Psittacosis; Radiography; Treatment Failure | 1997 |
[Pneumonia caused by Rhodococcus equi in patients with AIDS: difficulty in defining the most appropriate initial treatment].
Topics: Actinomycetales Infections; Adult; AIDS-Related Opportunistic Infections; Ciprofloxacin; Clarithromycin; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Erythromycin; Gentamicins; Humans; Male; Microbial Sensitivity Tests; Pneumonia, Bacterial; Rhodococcus equi; Rifampin; Vancomycin | 1997 |
Clarithromycin and azithromycin.
Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Humans; Otitis Media; Pneumonia, Bacterial; Soft Tissue Infections; Streptococcal Infections; Streptococcus pyogenes; Whooping Cough | 1998 |
Neisseria meningitidis W135 pneumonia with sepicaemia in a nonogenarian.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Clarithromycin; Female; Humans; Meningococcal Infections; Neisseria meningitidis; Pneumonia, Bacterial; Serotyping; Sinusitis | 1998 |
[The combination therapy of clarithromycin and sparfloxacin for pulmonary Mycobacterium gordonae infection].
Topics: Aged; Anti-Infective Agents; Antitubercular Agents; Clarithromycin; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Pneumonia, Bacterial; Treatment Outcome | 1999 |
In vitro and in vivo influence of adjunct clarithromycin on the treatment of mucoid Pseudomonas aeruginosa.
Topics: Animals; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Clarithromycin; Disease Models, Animal; Drug Therapy, Combination; Female; Humans; Mice; Microbial Sensitivity Tests; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Time Factors | 2000 |
Oral absorption of clarithromycin in acute illness and during convalescence in patients with community-acquired pneumonia.
Topics: Absorption; Acute Disease; Administration, Oral; Aged; Anti-Bacterial Agents; Clarithromycin; Community-Acquired Infections; Convalescence; Female; Humans; Male; Mouth Mucosa; Pneumonia, Bacterial; Prognosis; Prospective Studies; Radiography; Severity of Illness Index | 2000 |
Treatment of Chlamydia pneumoniae.
Topics: Adolescent; Amoxicillin-Potassium Clavulanate Combination; Antibodies, Bacterial; Azithromycin; Child; Child, Preschool; Chlamydophila Infections; Chlamydophila pneumoniae; Clarithromycin; Erythromycin; Humans; Pneumonia, Bacterial | 2000 |
[A case of pneumonia caused by Mycobacterium avium complex successfully treated with clarithromycin].
Topics: Aged; Anti-Bacterial Agents; Clarithromycin; Female; Humans; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Pneumonia, Bacterial | 2000 |
[Pulmonary Mycobacterium gordonae infection treated with clarithromycin].
Topics: Clarithromycin; Drug Resistance, Microbial; Female; Humans; Middle Aged; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Pneumonia, Bacterial; Treatment Outcome | 2000 |
Chlamydia pneumoniae, clarithromycin, and severe asthma.
Topics: Anti-Bacterial Agents; Asthma; Chlamydophila pneumoniae; Chronic Disease; Clarithromycin; Humans; Pneumonia, Bacterial | 2001 |
[Pneumonia caused by Nocardia nova].
Topics: Anti-Bacterial Agents; Clarithromycin; Diabetes Complications; Female; Humans; Middle Aged; Nocardia Infections; Opportunistic Infections; Pneumonia, Bacterial; Polymyositis; Treatment Outcome | 2001 |
Surgery for Mycobacterium avium complex lung disease in the clarithromycin era.
Topics: Adult; Aged; Antibiotic Prophylaxis; Clarithromycin; Cohort Studies; Female; Follow-Up Studies; Humans; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Pneumonectomy; Pneumonia, Bacterial; Postoperative Complications; Preoperative Care; Retrospective Studies; Treatment Outcome | 2002 |
[Soft-tissue abscess caused by Rhodococcus equi in a patient on hemodialysis].
Topics: Abscess; Actinomycetales Infections; Adrenal Cortex Hormones; Aged; Amikacin; Anti-Glomerular Basement Membrane Disease; Ciprofloxacin; Clarithromycin; Cyclophosphamide; Disease Susceptibility; Drug Therapy, Combination; Female; Humans; Imipenem; Immunocompromised Host; Immunosuppressive Agents; Kidney Failure, Chronic; Opportunistic Infections; Pneumonia, Bacterial; Renal Dialysis; Rhodococcus equi; Thigh | 2001 |
Complicated nosocomial pneumonia due to Legionella pneumophila in an immunocompromised child.
Topics: Anti-Bacterial Agents; Child, Preschool; Ciprofloxacin; Clarithromycin; Cross Infection; Drug Resistance, Multiple, Bacterial; Humans; Immunocompromised Host; Legionella pneumophila; Legionnaires' Disease; Male; Nutrition Disorders; Pneumonia, Bacterial | 2002 |